Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, March 25, 2014
[ Tue, Mar 25th 2014
] - WOPRAI
[ Tue, Mar 25th 2014
] - WOPRAI
[ Tue, Mar 25th 2014
] - WOPRAI
[ Tue, Mar 25th 2014
] - WOPRAI
Mon, March 24, 2014
[ Mon, Mar 24th 2014
] - WOPRAI
[ Mon, Mar 24th 2014
] - WOPRAI
Fri, March 21, 2014
[ Fri, Mar 21st 2014
] - WOPRAI
[ Fri, Mar 21st 2014
] - WOPRAI
[ Fri, Mar 21st 2014
] - WOPRAI
Thu, March 20, 2014
[ Thu, Mar 20th 2014
] - WOPRAI
[ Thu, Mar 20th 2014
] - WOPRAI
[ Thu, Mar 20th 2014
] - WOPRAI
[ Thu, Mar 20th 2014
] - WOPRAI
[ Thu, Mar 20th 2014
] - WOPRAI
Wed, March 19, 2014
[ Wed, Mar 19th 2014
] - WOPRAI
[ Wed, Mar 19th 2014
] - WOPRAI
[ Wed, Mar 19th 2014
] - WOPRAI
[ Wed, Mar 19th 2014
] - WOPRAI
Tue, March 18, 2014
[ Tue, Mar 18th 2014
] - WOPRAI
[ Tue, Mar 18th 2014
] - WOPRAI
[ Tue, Mar 18th 2014
] - WOPRAI
Mon, March 17, 2014
[ Mon, Mar 17th 2014
] - WOPRAI
[ Mon, Mar 17th 2014
] - WOPRAI
Fri, March 14, 2014
[ Fri, Mar 14th 2014
] - WOPRAI
David Risinger Upgraded (TEVA) to Hold and Held Target at $52 on, Mar 14th, 2014
David Risinger of Morgan Stanley, Upgraded "Teva Pharmaceutical Industries Limited" (TEVA) to Hold and Held Target at $52 on, Mar 14th, 2014.
David has made no other calls on TEVA in the last 4 months.
There are 3 other peers that have a rating on TEVA. Out of the 3 peers that are also analyzing TEVA, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Randall Stanicky of "RBC Capital" Initiated at Hold and Held Target at $39 on, Monday, January 6th, 2014
These are the ratings of the 2 analyists that currently disagree with David
- Ami Fadia of "Leerink Swann" Upgraded from Hold to Buy on, Thursday, March 6th, 2014
- Liav Abraham of "Citigroup" Maintained at Strong Buy with Increased Target to $56 on, Monday, March 3rd, 2014
